Additionally, it addresses the FDA’s communications Together with the applicant, the retention of documents that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer ownership of the SE report back to a new applicant and Digital submission of the SE repo